CASI Pharmaceuticals
CASI
#9690
Rank
HK$0.29 B
Marketcap
HK$19.04
Share price
-1.21%
Change (1 day)
-56.14%
Change (1 year)

EPS for CASI Pharmaceuticals (CASI)

EPS in 2022 (TTM): -HK$23.32

According to CASI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -HK$23.15. In 2021 the company made an earnings per share (EPS) of -HK$21.13 an increase over its 2020 EPS that were of -HK$33.95.

EPS history for CASI Pharmaceuticals from 1996 to 2022

Annual EPS

Year EPS Change
2022 (TTM)-HK$23.3210.37%
2021-HK$21.13-37.76%
2020-HK$33.95-8.96%
2019-HK$37.2950%
2018-HK$24.8677.78%
2017-HK$13.99-7.42%
2016-HK$15.11-11.63%
2015-HK$17.09-75.56%
2014-HK$69.93309.09%
2013-HK$17.09-72.84%
2012-HK$62.9368.75%
2011-HK$37.29-48.94%
2010-HK$73.03-19.66%
2009-HK$90.90-62.01%
2008-HK$239.30-0%
2007-HK$239.30-62.67%
2006-HK$640.98134.38%
2005-HK$273.49-13.51%
2004-HK$316.22-44.78%
2003-HK$572.61-62.36%
2002-HK$1,521-26.14%
2001-HK$2,060-20.72%
2000-HK$2,59813.43%
1999-HK$2,290150.47%
1998-HK$914.4794.55%
1997-HK$470.0627.91%
1996-HK$367.50